The reason was that necrotic tumor cells could release IL-1α to activate dendritic cells (DCs) which could induce an anti-tumor immune response by producing cytotoxic IL-12 or activating CD8+ T cells (Schmidt et al., 2015; Takemura et al., 2015). The gene discussed is IL1A; the disease is neoplasm.